Abstract
A low self-esteem and high levels of perceived stigma seem to be important factors for quality of life impairment in vitiligo patients. A simple visual analog scale from 0 to 10 with the notice ‘How much does your skin disease bother you currently?’ helps to measure coarsely how patients feel about their disease independently of medical findings. Patients with high perceived severity are the best targets of psychological interventions. Cognitive-behavioural therapy might help improve the quality of life, self-esteem and perceived body image.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Firooz A, Bouzari N, Fallah N, et al. What patients with vitiligo believed about their condition. Int J Dermatol. 2004;43:811–4.
Kent G, Al Abadie M. Factors affecting responses on dermatology life quality index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21:330–3.
Matoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16:573–8.
Porter JR, Beuf AH, Lerner A, Nordlund J. Psychosocial effect of vitiligo: a comparison of vitiligo patients with ‘normal’ control subjects, with psoriasis patients and patients with other pigmentary disorders. J Am Acad Dermatol. 1986;15:220–4.
Porter JR, Beuf AH, Lerner A, Nordlund J. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1:73–7.
Porter JR, Beuf AH, Lerner A, Nordlund J. The effect of vitiligo in sexual relationships. J Am Acad Dermatol. 1990;22:221–2.
Sampogna F, Raskovic D, Guerra L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008;159:351–9.
Picardi A, Abeni D, Melchi CF, et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognised. Br J Dermatol. 2000;143:983–91.
Kent G, Al’Abadie M. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol. 1996;35:895–8.
Matoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. J Dermatol. 2002;28:424–32.
Harlow B, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol. 2000;143:979–82.
Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of Vitiligo: a preliminary investigation into the effects of Cognitive-Behavioural Therapy. Br J Med Psychol. 1999;72:385–96.
Picardi A, Abeni D. Can Cognitive-Behavioural Therapy help patients with vitiligo? Arch Dermatol. 2001;137:786–8.
Salzer B, Schallreuter KU. Investigation of the personality structure in patients with vitiligo and a possible association with catecholamine metabolism. Dermatology. 1995;190:109–15.
Taieb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20:27–35.
Bonotis K, Pantelis K, Karaoulanis S, et al. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo. J Dtsch Dermatol Ges. 2016;14(1):45–9.
Kostopoulou P, Jouary T, Quintard B, et al. Objective vs subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol. 2009;161(1):128–33.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI). A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.
Finlay AY. Quality of Life Measurement in Dermatology: a practical guide. Br J Dermatol. 1997;136:305–14.
Shah R, Hunt J, Webb TL, Thompson AR. Starting to develop self-help for social anxiety associated with vitiligo: using clinical significance to measure the potential effectiveness of enhanced psychological self-help. Br J Dermatol. 2014;171(2):332–7.
Chan MF, Chua TL. The effectiveness of therapeutic interventions on quality of life for vitiligo patients: a systematic review. Int J Nurs Pract. 2012;18(4):396–405.
Eleftheriadou V, Whitton ME, Gawkrodger DJ, et al. Vitiligo priority setting partnership. Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership. Br J Dermatol. 2011;164(3):530–6.
Wang KY, Wang KH, Zhang ZP. Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2011;25(4):429–35.
Thompson AR, Clarke SA, Newell RJ, Gawkrodger DJ, Appearance Research Collaboration (ARC). Vitiligo linked to stigmatization in British South Asian women: a qualitative study of the experiences of living with vitiligo. Br J Dermatol. 2010;63(3):481–6.
Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol. 2005;152:1165–72.
Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, Eleftheriadou V, Ezzedine K. Evidence-based management of vitiligo: summary of a Cochrane systematic review. Br J Dermatol. 2016;174(5):962–9. https://doi.org/10.1111/bjd.14356. Epub 2016 Mar 25. Review.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kostopoulou, P., Taïeb, A. (2019). Psychological Interventions. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Cham. https://doi.org/10.1007/978-3-319-62960-5_42
Download citation
DOI: https://doi.org/10.1007/978-3-319-62960-5_42
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62958-2
Online ISBN: 978-3-319-62960-5
eBook Packages: MedicineMedicine (R0)